CCR5-Δ32 and IFNL4-ΔG/TT

被引：0
|
作者：
Jiang, Joy J. [1 ]
Fang, Michelle Z. [1 ]
Jackson, Sarah S. [1 ]
O'Brien, Thomas R. [1 ]
机构：
[1] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL THERAPEUTICS | 2019年 / 41卷 / 12期
基金：
美国国家卫生研究院;
关键词：
IFNL4;
D O I：
10.1016/j.clinthera.2019.10.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2658 / 2659
页数：2
相关论文
共 50 条
  • [31] Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutation
    Dean, M
    Jacobson, LP
    McFarlane, G
    Margolick, JD
    Jenkins, FJ
    Howard, OMZ
    Dong, HF
    Goedert, JJ
    Buchbinder, S
    Gomperts, E
    Vlahov, D
    Oppenheim, JJ
    O'Brien, SJ
    Carrington, M
    CANCER RESEARCH, 1999, 59 (15) : 3561 - 3564
  • [32] Distribution of the HIV resistance CCR5-Δ32 allele among Egyptians and Syrians
    Salem, Abdel-Halim
    Batzer, Mark A.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2007, 616 (1-2) : 175 - 180
  • [33] COMPARISON OF IFNL4-ΔG AND IFNL3 3′UTR rs4803217 GENOTYPES FOR ASSOCIATION WITH HCV TREATMENT RESPONSE
    O'Brien, T.
    Pfeiffer, R.
    Tang, W.
    Kuhs, K.
    Chen, S.
    Howell, C.
    Prokunina-Olsson, L.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S530 - S530
  • [34] Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers
    Jenkins, Frank J.
    Minas, Tsion Z.
    Tang, Wei
    Dorsey, Tiffany H.
    Ambs, Stefan
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Homozygous and heterozygous CCR5-Δ32 genotypes are associated with resistance to HIV infection
    Marmor, M
    Sheppard, HW
    Donnell, D
    Bozeman, S
    Celum, C
    Buchbinder, S
    Koblin, B
    Seage, GR
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (05) : 472 - 481
  • [36] Prevalence of the chemokine receptor CCR5-Δ32 gene mutation in periodontal disease
    Folwaczny, M
    Glas, J
    Török, HP
    Fricke, K
    Folwaczny, C
    CLINICAL IMMUNOLOGY, 2003, 109 (03) : 325 - 329
  • [37] No statistical evidence for an effect of CCR5-∆32 on lifespan in the UK Biobank cohort
    Robert Maier
    Ali Akbari
    Xinzhu Wei
    Nick Patterson
    Rasmus Nielsen
    David Reich
    Nature Medicine, 2020, 26 : 178 - 180
  • [38] Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?
    Arababadi, Mohammad K.
    Naghavi, Nima
    Hassanshahi, Gholamhossein
    Mahmoodi, Mehdi
    ANNALS OF SAUDI MEDICINE, 2009, 29 (05) : 413 - 413
  • [39] Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C
    Ahlenstiel, G
    Berg, T
    Woitas, RP
    Grünhage, F
    Iwan, A
    Hess, L
    Brackmann, HH
    Kupfer, B
    Schernick, A
    Sauerbruch, T
    Spengler, U
    JOURNAL OF HEPATOLOGY, 2003, 39 (02) : 245 - 252
  • [40] RETRACTED: CCR5-Δ32 is deleterious in the homozygous state in humans (Retracted Article)
    Wei, Xinzhu
    Nielsen, Rasmus
    NATURE MEDICINE, 2019, 25 (06) : 909 - +
12345